CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,541 | $10.20 | $36K | 53,978 |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −3,541 | $27.33 | $97K | 50,437 |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +4,166 | $14.25 | $59K | 54,603 |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −4,166 | $27.33 | $114K | 50,437 |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,348 | $27.58 | $175K | 44,089 |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,541 | 127,501 | ||
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −4,166 | 100,001 | ||
| 2026-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 56,786 |
| 2026-02-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −5,828 | $28.94 | $169K | 50,958 |
| 2026-02-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −521 | $29.64 | $15K | 50,437 |
| 2026-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,349 | 31,743 | ||
| 2026-02-09 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,171 | $16.00 | $35K | 52,608 |
| 2026-02-09 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,171 | $30.21 | $66K | 50,437 |
| 2026-02-09 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,171 | 26,047 | ||
| 2026-01-20 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +416 | $15.44 | $6K | 50,853 |
| 2026-01-20 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −416 | $32.10 | $13K | 50,437 |
| 2026-01-20 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −416 | 5,834 | ||
| 2026-01-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,367 | $32.61 | $371K | 50,437 |
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,542 | $10.20 | $36K | 65,346 |
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +4,167 | $14.25 | $59K | 69,513 |
Page 8 of 17 · 321 trades